Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Choice of Cell Source in Cell-Based Therapies for Retinal Damage due to Age-Related Macular Degeneration: A Review

1 Jan 2013

Abstract excerpt

Background. Age-related macular degeneration (AMD) is a complex disorder that affects primarily the macula involving the retinal pigment epithelium (RPE) but also to a certain extent the photoreceptor layer and the retinal neurons. Cell transplantation is a promising option for AMD and clinical trials are underway using different cell types. Methods. We hypothesize that instead of focusing on a particular cell...

Topics

Join the communities discussing this publication.

Retinal Development and Disorders
Retinal Diseases and Treatments
Retinal Imaging and Analysis

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 23710332
DOI: 10.1155/2013/465169

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Choice of Cell Source in Cell-Based Therapies for Retinal Damage due to Age-Related Macular Degeneration: A ReviewPMID 23710332Read ↗

Embryonic stem cells as a treatment for macular degenerationSemantic proximity Read ↗

Cell Therapy Replacement for Retinal and Optic Nerve Diseases: Cell Sources, Clinical Trials and ChallengesSemantic proximity Read ↗

Efficient Derivation of Retinal Pigment Epithelium Cells from Stem CellsSemantic proximity Read ↗

Stem Cell Therapy for Retinal Degeneration: The Evidence to DateSemantic proximity Read ↗

Regenerative medicine in the retina: from stem cells to cell replacement therapySemantic proximity Read ↗

AMD and Stem Cell-Based TherapiesSemantic proximity Read ↗

Where Are We with RPE Replacement Therapy? A Translational Review from the Ophthalmologist PerspectiveSemantic proximity Read ↗

Cellular models and therapies for age-related macular degenerationSemantic proximity Read ↗

Stem cells: a new paradigm for disease modeling and developing therapies for age-related macular degenerationSemantic proximity Read ↗

Retinal pigment epithelial cells as a therapeutic tool and target against retinopathies.Semantic proximity Read ↗

Pluripotent stem cell therapy for retinal diseasesSemantic proximity Read ↗

Amelioration of Photoreceptor Degeneration by Intravitreal Transplantation of Retinal Progenitor Cells in RatsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.